We are live on ! Find out more
NEPH icon

Nephros
NEPH

21 hedge funds and large institutions have $34.8M invested in Nephros in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

31% more funds holding

Funds holding: 16 → 21 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.73% less ownership

Funds ownership: 53.52% → 52.79% (-0.73%)

23% less capital invested

Capital invested by funds: $45.3M → $34.8M (-$10.5M)

Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
7
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CPA
Cowen Prime Advisors
New York
+$376K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$227K
3
Citadel Advisors
Citadel Advisors
Florida
+$145K
4
BA
Bard Associates
Illinois
+$98.8K
5
BlackRock
BlackRock
New York
+$32.1K

Top Sellers

Rank Fund Capital Flow
1
PHP
Parkman Healthcare Partners
Connecticut
-$1.43M
2
Millennium Management
Millennium Management
New York
-$17.3K
3
EP
Elkhorn Partners
Nebraska
-$2.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
1
Wexford Capital
Florida
$23.7M +$18K +2,284 +0.1%
CPA
2
Cowen Prime Advisors
New York
$4.14M +$376K +47,673 +8%
SC
3
Samjo Capital
New York
$3.66M – – –
BA
4
Bard Associates
Illinois
$1.46M +$98.8K +12,530 +6%
Vanguard Group
5
Vanguard Group
Pennsylvania
$640K +$227K +28,756 +43%
HighTower Advisors
6
HighTower Advisors
Illinois
$370K – – –
William Blair & Company
7
William Blair & Company
Illinois
$241K – – –
BlackRock
8
BlackRock
New York
$157K +$32.1K +4,071 +21%
Millennium Management
9
Millennium Management
New York
$126K -$17.3K -2,200 -10%
Citadel Advisors
10
Citadel Advisors
Florida
$123K +$145K +18,421 New
EP
11
Elkhorn Partners
Nebraska
$93K -$2.14K -271 -2%
Morgan Stanley
12
Morgan Stanley
New York
$25K – – –
SFS
13
Sowell Financial Services
Arkansas
$23K +$2.29K +291 +11%
SIC
14
Salem Investment Counselors
North Carolina
$23K +$27.6K +3,500 New
TCWM
15
Total Clarity Wealth Management
Illinois
$4K +$5.15K +653 New
UBS Group
16
UBS Group
Switzerland
$2K +$481 +61 +22%
TRCT
17
Tower Research Capital (TRC)
New York
$2K +$2.77K +351 New
PHP
18
Parkman Healthcare Partners
Connecticut
– -$1.43M -167,048 Closed
Bank of America
19
Bank of America
North Carolina
– +$197 +25 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– +$213 +27 New

NEPH Hedge Fund Activity: Q1 2021 in Review

21 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2021, worth a combined $34.8M — down 23% from $45.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NEPH positions and 1 closed out — a net gain of 5 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Cowen Prime Advisors, adding an estimated $376K. The largest seller was Parkman Healthcare Partners, exiting entirely with an estimated $1.43M sold.

  • 21 institutional investors held Nephros (NEPH) as of Q1 2021, up from 16 in Q4 2020.
  • Funds reported $34.8M of Nephros stock for Q1 2021, down 23% quarter-over-quarter.
  • 6 funds opened new Nephros positions in Q1 2021 and 1 closed out, a net change of +5 holders.
  • The largest Nephros buyer in Q1 2021 was Cowen Prime Advisors, an estimated $376K added.
  • The largest Nephros seller in Q1 2021 was Parkman Healthcare Partners, an estimated $1.43M sold.

Based on aggregated 13F filings for Q1 2021.